BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 9:54:00 AM | Browse: 1229 | Download: 1417
 |
Received |
|
2014-03-29 21:32 |
|
Peer-Review Started |
|
2014-03-31 11:41 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-04-16 11:05 |
|
Revised |
|
2014-04-30 12:25 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-07-14 17:08 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-07-14 17:33 |
|
Articles in Press |
|
2014-07-14 17:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-09-28 17:46 |
|
Publish the Manuscript Online |
|
2014-10-20 09:43 |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Glaucoma and Alzheimer's disease: Their clinical similarity and future therapeutic strategies for glaucoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tetsuya Sugiyama |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tetsuya Sugiyama, MD, PhD, Director, Nakano Eye Clinic of Kyoto Medical Co-operative, 2, Jurakumawari-higashimachi, Nakagyo-Ku, Kyoto, 604-8404, Japan. tsugiyama@poh.osaka-med.ac.jp |
| Key Words |
glaucoma; Alzheimer's disease; retinal ganglion cells; cerebral blood flow; amyloid-β |
| Core Tip |
This review summarizes studies describing the similarities between glaucoma and Alzheimer's disease, thereby suggesting new probable therapeutic strategies for glaucoma. |
| Publish Date |
2014-10-20 09:43 |
| Citation |
Sugiyama T. Glaucoma and Alzheimer's disease: Their clinical similarity and future therapeutic strategies for glaucoma. World J Ophthalmol 2014; 4(3): 47-51 |
| URL |
http://www.wjgnet.com/2218-6239/full/v4/i3/47.htm |
| DOI |
http://dx.doi.org/10.5318/wjo.v4.i3.47 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
